| Literature DB >> 31790463 |
Daria Chmielewska1, Magdalena Stania1, Katarzyna Kucab-Klich1, Edward Błaszczak2, Krystyna Kwaśna1, Agnieszka Smykla1, Dominika Hudziak3, Patrycja Dolibog2.
Abstract
The aim of this study was to compare the effect of pelvic floor muscle training with surface electromyographic (sEMG) biofeedback (BF group) and Pilates exercises (P group) on the bioelectrical activity of pelvic floor muscles in women with stress urinary incontinence. The other aim aim was to compare changes in voiding diaries and scores on quality of life questionnaire against baseline values and between the groups. Women in the BF group (n = 18) participated in pelvic floor muscle training with sEMG biofeedback; the P group (n = 13) participated in basic level Pilates workouts. Both protocols were continued for eight weeks. Voiding diary, quality of life and electromyographic characteristics of the pelvic floor muscles were assessed at the three-time points: at baseline, after eight weeks' training, and at month six post-training. The sEMG activity of the pelvic floor muscles was tested during five trials in two positions. There was no marked improvement in bioelectrical activity of the pelvic floor muscles during contraction following training with sEMG biofeedback or Pilates exercises. Following eight weeks of sEMG biofeedback training, a decrease was noted in resting bioelectrical activity of pelvic floor muscles and during relaxation after sustained contraction but only in supine-lying. No such effect was observed in the Pilates group. In the BF group, the number of incontinence episodes after end of treatment (timpepoints: 1vs. 2) and at six month follow-up (timpepoints: 1vs. 3) decreased by 68.5% and 89.3%, respectively. The respective values in the P group were 78.6%, and 86.4%. The intergroup differences did not reach the level of statistical significance. As regards the quality of life, the questionnaire demonstrated that Pilates exercises had significantly better effects compared to biofeedback training both at the end of the eight-week exercise program and (p = 0.003) and at six month follow-up (p = 0.0009). The International Consultation on Incontinence Questionnaire-Short Form (ICIQ- SF) showed comparable efficacy of Pilates exercises and training with sEMG biofeedback. Intragroup improvements in micturition frequency, incontinence (leakage) episodes, and nocturia frequency were comparable. Alleviation of urinary incontinence symptoms was comparable in both groups, whereas the improvement in the quality of life was more notable in the Pilates group. The obtained results failed to demonstrate the superiority of any of the two methods regarding the bioelectrical activity of pelvic floor muscles in patients with stress urinary incontinence.Entities:
Mesh:
Year: 2019 PMID: 31790463 PMCID: PMC6886793 DOI: 10.1371/journal.pone.0225647
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of characteristics of study participants.
| Characteristics | BF group n = 18 | P group n = 13 | p-value |
|---|---|---|---|
| mean ± SD or n (%) | mean ± SD or n (%) | ||
| Age | 52.9 ± 4 | 51.5–6 ± 5.2 | 0.57 |
| BMI | 24.5 ± 3.04 | 23.7 ± 2.6 | 0.41 |
| BMI <30kg/m2 | 17 (94.44%) | 13 (100%) | 0.5 |
| BMI > 30kg/m2< 33kg/m2 | 1 (5.56%) | 0 (0%) | 0.5 |
| Number of pregnancies | |||
| none | 0 | 1 (7.7%) | 0.2 |
| one time | 3 (16.67%) | 1 (7.7%) | 0.45 |
| two time | 9 (50%) | 6 (46.1%) | 0.83 |
| three time | 5 (27.78%) | 4 (30.8%) | 0.79 |
| four time | 1 (5.55%) | 1 (7.7%) | 0.89 |
| Cesarean section | |||
| none | 13 (72.22%) | 11 (84.6%) | 0.4 |
| one time | 3 (16.67%) | 1 (7.7%) | 0.68 |
| two time | 2 (11.11%) | 1 (7.7%) | 0.81 |
| Vaginal delivery | |||
| none | 2 (11,11%) | 1 (7.7%) | 0.75 |
| one time | 4 (22.22%) | 2 (15.4%) | 0.63 |
| Two time | 7 (38.8%) | 7 (53.8%) | 0.41 |
| three time | 5 (27.7%) | 2 (15.4%) | 0.4 |
| four time | 0 (0%) | 1 (7.7%) | 0.2 |
| Current hormonal therapy | |||
| no | 14 (77.78%) | 8 (61.5%) | 0.33 |
| yes | 4 (22.22%) | 5 (38.5%) | 0.33 |
* U Mann Whitney test
** Chi square test (χ2)
Comparison of symptom severity (based on voiding diaries) and quality of life at three measurement time points.
| Group BF | Group P | p**intergroup BF vs. P | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | ||||||||
| Micturition frequency | 8.09 ± 2.71 | 6.76 ± 1.68 | 6.96 ± 1.2 | 0.023 | >0.05 | 0.04 | >0.05 | 7.67 ± 2.61 | 7.26 ± 1.8 | 6.95 ± 1.9 | 0.67 | >0.05 | >0.05 | >0.05 | 0.56 | 0.54 | 0.6 |
| Mdn | 7.83 | 7 | 7.31 | 7 | 7 | 6.67 | |||||||||||
| Q1 | 6.08 | 5.83 | 6.08 | 5.33 | 6.67 | 6 | |||||||||||
| Q3 | 9.53 | 7.92 | 8 | 8.67 | 8.33 | 7 | |||||||||||
| Nocturia frequency | 0.65 ± 0.51 | 0.39 ± 0.32 | 0.23 ± 0.21 | 0.002 | >0.05 | 0.02 | >0.05 | 0.51 ± 3.89 | 0.25 ± 0.27 | 0.23 ± 0.23 | 0.032 | >0.05 | >0.05 | >0.05 | 0.51 | 0.37 | 0.62 |
| Mdn | 0.33 | 0.33 | 0.12 | 0.33 | 0.33 | 0 | |||||||||||
| Q1 | 0.33 | 0 | 0 | 0.33 | 0 | 0 | |||||||||||
| Q3 | 1 | 0.67 | 0.33 | 1 | 0.33 | 0.33 | |||||||||||
| Incontinence episodes | 1.78 ± 1.01 | 0.56 ± 0.76 | 0.19 ± 0.28 | <0.0001 | 0.01 | 0.01 | >0.05 | 1.69 ± 1 | 0.36 ± 0.37 | 0.23 ± 0.56 | <0.001 | 0.01 | 0.01 | >0.05 | 0.8 | 0.73 | 0.46 |
| Mdn | 2 | 0.333 | 0 | 1.67 | 0.33 | 0 | |||||||||||
| Q1 | 0.75 | 0 | 0 | 1 | 0 | 0 | |||||||||||
| Q3 | 2.33 | 0.67 | 0.33 | 2.33 | 0.67 | 0 | |||||||||||
| part 1 KHQ score | 108.24 ± 41.6 | 73.15 ± 40.17 | 64.706 ± 24.5 | 0.0008 | 0.05 | 0.01 | >0.05 | 93.75 ± 38.12 | 51.39 ± 26.6 | 40.97 ± 24.5 | 0.004 | >0.05 | 0.02 | >0.05 | 0.43 | 0.08 | 0.02 |
| Mdn | 91.67 | 58.33 | 58.33 | 87.5 | 58.33 | 33.33 | |||||||||||
| Q1 | 83.33 | 58.33 | 58.33 | 58.33 | 33.33 | 25 | |||||||||||
| Q3 | 147.92 | 89.58 | 83.33 | 100 | 58.33 | 58.33 | |||||||||||
| part 2 KHQ score | 180.01 ± 91.2 | 156.79 ± 85.05 | 144.248 ± 78.67 | p<0.019 | >0.05 | 0.01 | >0.05 | 123.46 ± 48.56 | 76.62 ± 40.22 | 63.97 ± 37.8 | 0.017 | >0.05 | 0.03 | >0.05 | 0.09 | 0.003 | 0.0009 |
| Mdn | 151.25 | 136.11 | 138.89 | 121.33 | 66.67 | 64.39 | |||||||||||
| Q1 | 121.39 | 91.67 | 92.36 | 97.22 | 56.25 | 14.58 | |||||||||||
| Q3 | 198.25 | 219.44 | 174.31 | 142.36 | 105.56 | 100 | |||||||||||
| ICIQ -SF | 12.83 ± 3.68 | 8.56 ± 4.03 | 7.39 ± 2.38 | 0.00065 | 0.03 | 0.01 | >0.05 | 11.73 ± 4.01 | 6.73 ± 2.76 | 6.07 ± 3.06 | p<0.001 | 0.02 | 0.01 | >0.05 | 0.34 | 0.19 | 0.09 |
| Mdn | 13.5 | 8 | 8 | 12 | 6 | 6 | |||||||||||
| Q1 | 12 | 5.25 | 5.5 | 8.5 | 5 | 4.5 | |||||||||||
| Q3 | 14.75 | 12 | 9 | 14 | 7 | 6.5 | |||||||||||
Mdn–median, Q1—lower quartile, Q3- upper quartile, KHQ- King's Health Quality of Life Questionnaire, ICIQ—The International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form
p* (1, 2, 3)—Friedman's ANOVA, p 1 vs. 2, 1 vs. 3, 2 vs. 3—Post-hoc Friedman's rank sum test
p** Mann- Whitney U test.
Fig 1Intra- and intergroup analysis of sEMG mean %MVC amplitudes of the resting activity of pelvic floor muscles; p* Post-hoc Friedman's rank sum test; p** Mann- Whitney U test.
Fig 8Intra- and intergroup analysis of sEMG average peak %MVC amplitudes of the relaxation of the pelvic floor muscles; p* Post-hoc Friedman's rank sum test.
Fig 2Intra- and intergroup analysis of sEMG average peak %MVC amplitudes of the resting activity of pelvic floor muscles; p* Post-hoc Friedman's rank sum test; p** Mann- Whitney U test.
Fig 3Intra- and intergroup analysis of sEMG average peak %MVC amplitudes of the short contraction of the pelvic floor muscles; p* Post-hoc Friedman's rank sum test.
Fig 4Intra- and intergroup analysis of sEMG mean %MVC amplitudes of the short contraction of the pelvic floor muscles; p* Post-hoc Friedman's rank sum test.
Fig 5Intra- and intergroup analysis of sEMG mean %MVC amplitudes of the 5 repetitions of 10-second voluntary contraction of pelvic floor muscles; p* Post-hoc Friedman's rank sum test; p** Mann- Whitney U test.
Fig 6Intra- and intergroup analysis of sEMG average peak %MVC amplitudes of the 5 repetitions of 10-second voluntary contraction of pelvic floor muscles; p* Post-hoc Friedman's rank sum test; p** Mann- Whitney U test.
Fig 7Intra- and intergroup analysis of sEMG mean %MVC amplitudes of the relaxation of the pelvic floor muscles; p* Post-hoc Friedman's rank sum test.
Intra- and intergroup analysis of sEMG amplitude of the sustained 60-second contraction of the pelvic floor muscles.
| group BF sustained contraction | group P sustained contraction | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Positions | median frequency (Hz) ± SD | mean frequency (Hz) ± SD | RMS EMG (μV)± SD | median frequency (Hz) ± SD | mean frequency (Hz) ± SD | RMS EMG (μV)± SD | median frequency (Hz) ± SD | mean frequency (Hz) ± SD | RMS EMG (μV)± SD |
| supine 1 | 75.7 ± 15.4 | 90.6 ± 19.1 | 12.7 ± 9.7 | 76.7 ± 10.2 | 96.5 ± 13.9 | 12.8 ± 8 | 0.9 | 0.3 | 0.6 |
| supine 2 | 72.84 ± 13.5 | 88.7 ± 14.3 | 15.1 ± 7.4 | 79.2 ± 15.5 | 96.2 ± 18.9 | 17.1 ± 8.2 | 0.3 | 0.2 | 0.6 |
| supine 3 | 72.2± 13.1 | 87.5 ± 15.3 | 15.4 ± 6.5 | 74.4 ± 19.7 | 90.7 ± 20.42 | 15.9 ± 9.1 | 0.7 | 0.6 | 0.8 |
| standing 1 | 61.26 ± 12.66 | 76.46 ± 16.02 | 14.9 ± 9.4 | 59.2 ± 11.21 | 75.3 ± 12.26 | 16.7 ± 7 | 0.6 | 0.4 | 0.3 |
| standing 2 | 55.12 ± 12.92 | 69.9.59 ± 12.1 | 17.36 ± 8.17 | 67.92 ± 16.5 | 83.7 ± 17.3 | 21.5 ± 9.7 | 0.02 | 0.03 | 0.3 |
| standing 3 | 56.47± 6.42 | 71.6 ± 8.19 | 18.41 ± 9.5 | 62.6 ± 5.7 | 77.35 ± 5.81 | 22.2 ± 9.4 | 0.01 | 0.02 | 0.3 |
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
| 0.05 | >0.05 | >0.05 | 0.01 | 0.01 | >0.05 | ||||
| 0.01 | 0.01 | >0.05 | 0.04 | 0.01 | >0.05 | ||||
| >0.05 | 0.02 | >0.05 | >0.05 | >0.05 | >0.05 | ||||
p* (1 2 3)—Friedman's ANOVA
p—Post-hoc Friedman's rank sum test
p** Mann-Whitney U test
Fig 9a-d. Intra- and intergroup analysis the number of women with an increase (>0 (n)) in the resting activity and 10-second relaxation sEMG; p Chi square test (χ2).